Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NHL or HL”

9 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 9 of 9 results

Testing effectiveness (Phase 2)Looking for participantsNCT04888741
What this trial is testing

Methods of T Cell Depletion Trial (MoTD)

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaChronic Myelomonocytic Leukemia+6 more
University of Birmingham 400
Testing effectiveness (Phase 2)Study completedNCT00481871
What this trial is testing

Study of Pralatrexate & Gemcitabine With B12 & Folic Acid to Treat Relapsed/Refractory Lymphoproliferative Malignancies

Who this might be right for
Relapsed or Refractory Lymphoproliferative MalignanciesHodgkin's LymphomaPeripheral T-cell Lymphoma+2 more
Acrotech Biopharma Inc. 119
Testing effectiveness (Phase 2)Looking for participantsNCT04644016
What this trial is testing

Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders

Who this might be right for
AMLALLMDS+6 more
Memorial Sloan Kettering Cancer Center 31
Early research (Phase 1)Looking for participantsNCT05272384
What this trial is testing

Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma

Who this might be right for
Recurrent B-Cell Non-Hodgkin LymphomaRecurrent Diffuse Large B-Cell LymphomaRecurrent Hodgkin Lymphoma+3 more
National Cancer Institute (NCI) 32
Early research (Phase 1)Active Not RecruitingNCT03150329
What this trial is testing

Pembrolizumab and Vorinostat in Patients With Relapsed or Refractory DLBCL, FCL or HL.

Who this might be right for
Grade 3b Follicular LymphomaRecurrent B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between DLBCL and Classic HLRecurrent Classic Hodgkin Lymphoma+13 more
City of Hope Medical Center 52
Early research (Phase 1)WithdrawnNCT04233697
What this trial is testing

Copanlisib in Combination With Romidepsin in Patients With Relapsed or Refractory Mature T-cell Lymphoma

Who this might be right for
Lymphoma, T-Cell
Columbia University
Early research (Phase 1)Study completedNCT02223052
What this trial is testing

Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies

Who this might be right for
Hematological NeoplasmsNon-Hodgkin's LymphomaHodgkin's Lymphoma+17 more
Celgene 89
Testing effectiveness (Phase 2)Study completedNCT00670592
What this trial is testing

Study of HCD122 in Adults With Non-Hodgkin's or Hodgkin's Lymphoma Who Have Progressed After at Least Two Prior Therapies

Who this might be right for
Non-Hodgkin's LymphomaHodgkin's Lymphoma
Novartis Pharmaceuticals 111
Testing effectiveness (Phase 2)Ended earlyNCT01964755
What this trial is testing

Chemotherapy for Relapsed Epstein Barr Virus Associated Lymphoma

Who this might be right for
Epstein Barr Virus Associated Non Hodgkin's LymphomaEpstein Barr Virus Associated Hodgkin's LymphomaPost-Transplant Lymphoproliferative Disease
University of Miami 6